Oncopatch, Inc.

Oncopatch, Inc. — FDA 510(k) Submissions

Oncopatch, Inc. has submitted 1 FDA 510(k) premarket notifications since 2025, of which 1 received clearance as substantially equivalent to a predicate device.

The company's most frequent device categories include Source, Brachytherapy, Radionuclide . Use the specialty filter in the sidebar to narrow results.